RPS10

Across TCGA pan-cancer cohorts, RPS10 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated RPS10 data layer compared with 27 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher RPS10 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS10 expression acts as an unfavorable survival marker.

CESC are the cancer types where RPS10 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Median	All	0.193	0.740	.010	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

RPS10–CESC (DFS)

Open the CESC breakdown →